- freely available
- re-usable
Mar. Drugs 2010, 8(4), 1373-1393; doi:10.3390/md8041373
Review
The Outer Vestibule of the Na+ Channel–Toxin Receptor and Modulator of Permeation as Well as Gating
Institute of Pharmacology, Centre of Physiology and Pharmacology, Medical University of Vienna, 1090 Vienna, Austria
These authors contributed equally to the manuscript.
* Author to whom correspondence should be addressed.
Received: 3 February 2010; in revised form: 31 March 2010 / Accepted: 19 April 2010 / Published: 21 April 2010
(This article belongs to the Special Issue Tetrodotoxin)
Abstract: The outer vestibule of voltage-gated Na+ channels is formed by extracellular loops connecting the S5 and S6 segments of all four domains (“P-loops”), which fold back into the membrane. Classically, this structure has been implicated in the control of ion permeation and in toxin blockage. However, conformational changes of the outer vestibule may also result in alterations in gating, as suggested by several P-loop mutations that gave rise to gating changes. Moreover, partial pore block by mutated toxins may reverse gating changes induced by mutations. Therefore, toxins that bind to the outer vestibule can be used to modulate channel gating.
Keywords: tetrodotoxin; saxitoxin; sodium channel; use-dependent block; rate-dependent block; outer vestibule
Article Statistics
Click here to load and display the download statistics.Cite This Article
MDPI and ACS Style
Cervenka, R.; Zarrabi, T.; Lukacs, P.; Todt, H. The Outer Vestibule of the Na+ Channel–Toxin Receptor and Modulator of Permeation as Well as Gating. Mar. Drugs 2010, 8, 1373-1393.
AMA StyleCervenka R, Zarrabi T, Lukacs P, Todt H. The Outer Vestibule of the Na+ Channel–Toxin Receptor and Modulator of Permeation as Well as Gating. Marine Drugs. 2010; 8(4):1373-1393.
Chicago/Turabian StyleCervenka, René; Zarrabi, Touran; Lukacs, Peter; Todt, Hannes. 2010. "The Outer Vestibule of the Na+ Channel–Toxin Receptor and Modulator of Permeation as Well as Gating." Mar. Drugs 8, no. 4: 1373-1393.
Mar. Drugs
EISSN 1660-3397
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert
